{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:30:38Z","timestamp":1759336238963},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:00:00Z","timestamp":1649635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00520-022-07014-5","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T09:03:55Z","timestamp":1649667835000},"page":"6013-6020","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Use of a buprenorphine-based pain management protocol is associated with reduced opioid requirements and pain on swallowing in oral mucositis: a retrospective cohort study"],"prefix":"10.1007","volume":"30","author":[{"given":"Ilonka","family":"Meyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Dube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Yeomans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Pontonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Heldreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stiofan","family":"O\u2019Conghaile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Maroon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong O.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,11]]},"reference":[{"key":"7014_CR1","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1007\/s00520-013-1871-y","volume":"21","author":"DP Saunders","year":"2013","unstructured":"Saunders DP, Epstein JB, Elad S et al (2013) Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support. Care Cancer Off. J Multinatl Assoc Support Care Cancer 21:3191\u2013207","journal-title":"J Multinatl Assoc Support Care Cancer"},{"key":"7014_CR2","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1053\/j.jvca.2015.01.026","volume":"29","author":"MS Angst","year":"2015","unstructured":"Angst MS (2015) Intraoperative Use of Remifentanil for TIVA: Postoperative pain, acute tolerance, and opioid-induced hyperalgesia. J Cardiothorac Vasc Anesth Elsevier 29:S16-22","journal-title":"J Cardiothorac Vasc Anesth Elsevier"},{"key":"7014_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00001756-200301200-00001","volume":"14","author":"G Simonnet","year":"2003","unstructured":"Simonnet G, Rivat C (2003) Opioid-induced hyperalgesia: abnormal or normal pain? NeuroReport 14:1\u20137","journal-title":"NeuroReport"},{"key":"7014_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12987-017-0080-3","volume":"14","author":"CP Schaefer","year":"2017","unstructured":"Schaefer CP, Tome ME, Davis TP (2017) The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse. Fluids Barriers CNS 14:32","journal-title":"Fluids Barriers CNS"},{"key":"7014_CR5","unstructured":"Ooi K: Faculty of Pain Medicine | ANZCA: Official Opioid Dose Equivalence. [Internet]FPMANZCA Prof. Doc. [Internet]2019 [cited 2021]Retrieved from: http:\/\/www.anzca.edu.au\/documents\/anzcafpm-good-prescribing-practice-20150814.pdf"},{"key":"7014_CR6","unstructured":"Nielsen S, National Drug and Alcohol Research Centre (Australia): Comparing opioids: a guide to estimating oral morphine equivalents (OME) in research. 2014,"},{"key":"7014_CR7","unstructured":"Voorhis C, Morgan B: Understanding power and rules of thumb for determining sample size. Tutor. Quant. Methods Psychol. 32007"},{"key":"7014_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.4103\/0970-9185.117095","volume":"29","author":"AM Hussain","year":"2013","unstructured":"Hussain AM, Khan FA, Ahmed A et al (2013) Effect of gender on pain perception and analgesic consumption in laparoscopic cholecystectomy: An observational study. J Anaesthesiol Clin Pharmacol 29:337\u2013341","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"7014_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/00000542-200507000-00023","volume":"103","author":"F Aubrun","year":"2005","unstructured":"Aubrun F, Salvi N, Coriat P et al (2005) Sex- and age-related differences in morphine requirements for postoperative pain relief. Anesthesiology 103:156\u2013160","journal-title":"Anesthesiology"},{"key":"7014_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0304-3959(97)00059-6","volume":"72","author":"BA Coda","year":"1997","unstructured":"Coda BA, O\u2019Sullivan B, Donaldson G et al (1997) Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain 72:333\u2013346","journal-title":"Pain"},{"key":"7014_CR11","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1023\/A:1015994030251","volume":"5","author":"SD Roy","year":"1988","unstructured":"Roy SD, Flynn GL (1988) Solubility and Related Physicochemical Properties of Narcotic Analgesics. Pharm Res 5:580\u2013586","journal-title":"Pharm Res"},{"key":"7014_CR12","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.jpainsymman.2010.02.003","volume":"39","author":"S Vokurka","year":"2010","unstructured":"Vokurka S, Skardova J, Karas M et al (2010) Oropharyngeal mucositis pain treatment with transdermal buprenorphine in patients after allogeneic stem cell transplantation. J Pain Symptom Manage 39:e4-6","journal-title":"J Pain Symptom Manage"},{"key":"7014_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejpain.2008.04.011","volume":"13","author":"HG Kress","year":"2009","unstructured":"Kress HG (2009) Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Eur J Pain Lond Engl 13:219\u2013230","journal-title":"Eur J Pain Lond Engl"},{"key":"7014_CR14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1460-9592.2010.03358.x","volume":"20","author":"PJ James","year":"2010","unstructured":"James PJ, Howard RF, Williams DG (2010) The addition of ketamine to a morphine nurse- or patient-controlled analgesia infusion (PCA\/NCA) increases analgesic efficacy in children with mucositis pain. Paediatr Anaesth 20:805\u2013811","journal-title":"Paediatr Anaesth"},{"key":"7014_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1460-9592.2010.03515.x","volume":"21","author":"MC White","year":"2011","unstructured":"White MC, Hommers C, Parry S et al (2011) Pain management in 100 episodes of severe mucositis in children. Paediatr Anaesth 21:411\u2013416","journal-title":"Paediatr Anaesth"},{"key":"7014_CR16","doi-asserted-by":"publisher","first-page":"e28573","DOI":"10.1002\/pbc.28573","volume":"67","author":"S Prakash","year":"2020","unstructured":"Prakash S, Meena JP, Gupta AK et al (2020) Ketamine mouthwash versus placebo in the treatment of severe oral mucositis pain in children with cancer: A randomized double-blind placebo-controlled trial. Pediatr Blood Cancer 67:e28573","journal-title":"Pediatr Blood Cancer"},{"key":"7014_CR17","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s00520-017-3627-6","volume":"25","author":"A Shillingburg","year":"2017","unstructured":"Shillingburg A, Kanate AS, Hamadani M et al (2017) Treatment of severe mucositis pain with oral ketamine mouthwash. Support. Care Cancer Off. J Multinatl Assoc Support Care Cancer 25:2215\u20139","journal-title":"J Multinatl Assoc Support Care Cancer"},{"key":"7014_CR18","first-page":"989","volume":"12","author":"AJ Ryan","year":"2009","unstructured":"Ryan AJ, Lin F, Atayee RS (2009) Ketamine mouthwash for mucositis pain. J. Palliat. Med Mary Ann Liebert Inc publishers 12:989\u201391","journal-title":"Med Mary Ann Liebert Inc publishers"},{"key":"7014_CR19","unstructured":"Lin Y-C, Sentivany-Collins S: The analgesic response to intravenous lidocaine in the treatment of mucositis pain in children. [Internet]Abstr. - Anesthesiol. Annu. Meet. [Internet] American Society of Anesthesiologists[cited 2022]Retrieved from: http:\/\/www.asaabstracts.com\/strands\/asaabstracts\/abstract.htm?year=2000&index=15&absnum=1228"},{"key":"7014_CR20","doi-asserted-by":"publisher","first-page":"S-1","DOI":"10.6004\/jnccn.2008.2001","volume":"6","author":"W Bensinger","year":"2008","unstructured":"Bensinger W, Schubert M, Ang K-K et al (2008) NCCN Task Force Report: Prevention and Management of Mucositis in Cancer Care. J Natl Compr Canc Netw 6:S-1-S-21","journal-title":"J Natl Compr Canc Netw"},{"key":"7014_CR21","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/sj.bmt.1704515","volume":"33","author":"F Demarosi","year":"2004","unstructured":"Demarosi F, Lodi G, Soligo D et al (2004) Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain. Bone Marrow Transplant 33:1247\u20131251","journal-title":"Bone Marrow Transplant"},{"key":"7014_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.5694\/mja16.00133","volume":"204","author":"SA Schug","year":"2016","unstructured":"Schug SA, Palmer GM, Scott DA et al (2016) Acute pain management: scientific evidence, fourth edition, 2015. Med J Aust 204:315\u20137","journal-title":"Med J Aust"},{"key":"7014_CR23","doi-asserted-by":"publisher","first-page":"e0182021","DOI":"10.1371\/journal.pone.0182021","volume":"12","author":"M Kishimoto","year":"2017","unstructured":"Kishimoto M, Akashi M, Tsuji K et al (2017) Intensity and duration of neutropenia relates to the development of oral mucositis but not odontogenic infection during chemotherapy for hematological malignancy. PLOS ONE Public Library of Science 12:e0182021","journal-title":"PLOS ONE Public Library of Science"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07014-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-07014-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07014-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T09:29:27Z","timestamp":1653557367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-07014-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,11]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["7014"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-07014-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,11]]},"assertion":[{"value":"12 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for retrospective cohort study obtained (QI\/17\/Austin\/0831).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The author consents to be included as an author in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The author consents to be included as an author in the publication of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"0 = None1 = Oral soreness, erythema2 = Oral erythema, ulcers, solid diet tolerated3 = Oral ulcers, only liquid diet tolerated4 = Oral intake impossible","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Appendix 1a World Health Organisation Oral Mucositis Grading Scale"}},{"value":"0 = Awake and alert*S = Patient asleep but rousable1 = Easily rousable2 = Persistently drowsy, unable to stay awake spontaneously >10 seconds3 = Difficult to rouse or unresponsive*Sedation Scores entered as \u201cS\u201d were considered a score of 0.5 for the purposes of quantitative analysis.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Appendix 1b Modified Macintyre Sedation Scale"}}]}}